Molecular mechanisms of sepsis

Langenbeck's Archives of Surgery

Volumn 383, Issue 1, 1998, Pages 2-10

  Woltmann, A ^a,b   Hamann, L ^a   Ulmer, A J ^a   Gerdes, J ^a   Bruch, H P ^b   Rietschel, E T ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Endotoxin; Molecular mechanisms; Sepsis

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; ENDOTOXIN; ENDOTOXIN ANTIBODY; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN;

CELL ACTIVATION; CLINICAL TRIAL; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TOXIN ANALYSIS; TOXIN STRUCTURE;

ANTIGENS, CD14; ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; PROGNOSIS; SHOCK, SEPTIC; SURGICAL WOUND INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031978973     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050085     Document Type: Review

References (80)

1. Ayala A, Ertel W, Chaudry IH (1996) Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90
2. Bahrami S, Yao Y-M, Leichtfried G, Redl H, Schlag G, Di Padova FE (1997) Monoclonal antibody to endotoxin attenuates hemorrhage-induced lung injury and mortality in rats. Crit Care Med 25:1030-1036
3. Bailat S, Heumann D, Le Roy D, Baumgartner JD, Rietschel ET, Glauser MP, Di Padova F (1997) Similarities and disparities between core-specific and 0-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Infect Immun 65:811-814
4. Bauer M (1996) Pathophysiologie der Sepsis. Aktuelle Konzepte. Anaesthesist 45:312-322
5. Bhakdi S, Walev I, Jonas D, Plamer M, Weller U, Suttorp N, Grimminger F, Seeger W (1996) Pathogenesis of sepsis syndrome: possible relevance of pore-forming bacterial toxins. Curr Top Microbiol Immunol 216:101-118
6. Boyle EM Jr, Pohlmann TH, Johnson MC, Verrier ED (1997) Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 63:277-284
7. Brouckaert P, Fiers W (1996) Tumor necrosis factor and the systemic inflammatory response syndrome. Curr Top Microbiol Immunol 216:167-182
8. Bufler P, Stiegler G, Schuchmann M, Hess S, Krüger C, Stelter F, Eckerskorn C, Schütt C, Engelmann H (1995) Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD 14 transfectants. Eur J Immunol 25:604-610
9. Christ WJ, Asano O, Robidoux ALC, Perez M, Wang Y, Dubuc GR, Gavin WE, Hawkins LD, McGuinness PD, Mullarkey MA, Lewis MD, Kishi Y, Kawata T, Bristol JR, Rose JR, Rossignol DP, Kobayashi S, Hishinuma I, Kimura A, Asakawa A, Asakawa N, Katayama K, Yamatsu I (1995) E5531, a pure endotoxin antagonist of high potency. Science 268:80-83
10. Deitch EA, Berg R (1987) Endotoxin promotes translocation of bacteria from the gut. Arch Surg 122:185-190
11. Deitch EA, Rutan R, Waymack JP (1996) Trauma, shock, and gut translocation. New Horiz 4:289-299
12. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR (1995) The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple orsan failure Proc Natl Acad Sci (USA) 92:10359-10363
13. Di Padova FE, Brade H, Barclay GR, Poxton IR, Liehl E, Schuetze E, Kocher HP, Ramsay G, Schreier MH, McClelland DBL, Rietschel ET (1993) A broadly cross-reactive monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun 61:3863-3872
14. Edmiston CE. Condon RE (1991) Bacterial translocation. Surg Gynecol Obstet 173:73-83
15. El-Samalouti VT, Schletter J, Brade H, Brade L, Kusumoto S, Rietschel ET, Flad H-D. Ulmer AJ (1997) Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies. Eur J Biochem 250:418-424
16. Elsbach P, Weiss J (1993) The bactericidal/permeability-increasing protein (BPI), a potent element in host defense against gramnegative bacteria and lipopolysaccharide. Immunobiol 187:417-429
17. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697-1702
18. Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H (1993) Prevention of endotoxin-induced monokine release by human low-and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 61:5140-5146
19. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176-1665-1671
20. Galanos C, Lüderitz O, Rietschel ET, Westphal O, Brade H. Brade L, Freudenberg MA, Schade FU, Imoto M, Yoshimura S, Kusomoto S, Shiba T (1985) Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 148:1-5
21. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP (1994) Mode of action of anti-lipopolysaccaride-binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci (USA) 91:7922-7926
22. Gianotti L, Braga M, Vaiani R, Almondo F, Di Carlo V (1996) Experimental gut-derived endotoxaemia and bacteraemia are reduced by systemic administration of monoclonal anti-LPS antibodies. Burns 22:120-124
23. Go LL, Healey PJ, Watkins SC, Simmons RL, Rowe MI (1995) The effect of endotoxin on intestinal mucosal permeability to bacteria in vitro. Arch Surg 130:53-58
24. Golenbock D, Liu Y, Millham F, Freeman M, Zoeller RA (1993) Surface expression of human CD14 in chinese hamster ovary fibroblasts imparts macrophase-like responses to bacterial endotoxin. J Biol Chem 268:22055-22059
25. Haziot A, Ferrero E, Koentgen F, Htjiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM (1996) Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414.
26. Heeg K, Miethke T, Wagner H (1996) Superantigen-mediated lethal shock: the functional state of hgand-reactive T cells. Curr Top Microbiol Immunol 216:83-100
27. Ingalls RR, Golenbock TD (1995) CD11c/CD18. a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 181:1473-1479
28. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Fürll B, Freudenberg M, Schmitz G, Stelter F, Schütt C (1997) Lipopolysaccharide-binding protein is required to combat a murine Gram-nesative bacterial infection. Nature 389:742-745
29. Jenny NV, Günther E, Jann K (1977) Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection. Infect Immun 15:26-32
30. JonesGR, Lowes JA (1996) The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. QJM 89:515-522
31. Kellum JA, Decker JM (1996) The immune system: relation to sepsis and multiple organ failure. AACN Clin Issues 7:339-350
32. Knaus WA, Harrell FE, La Brecque JF, Wagner DP, Pribble JP, Draper EA, Fisher CJ Jr, Soll L (1996) Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis The rhlL-1ra Phase III Sepsis Syndrome Study Group. Crit Care Med 24:46-56
33. Koch T, Duneker HP, Axt R, Schiefer HG, van Ackern K, Neuhof H (1993) Alterations of bacterial clearance induced by endotoxin and tumor necrosis factor. Infect Immun 61:3143-3148.
34. Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ (1992) Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccaride (LPS) and LPS-binding protein. J Exp Med 175:1697-1705
35. Loppnow H, Stelter F, Schönbeck U, Schlüter C, Ernst M, Schütt C, Flad HD (1995) Endotoxin activates human vascular smooth muscle cells despide lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 63:1020-1026
36. Luo G, Niesel DW, Shaban RA, Grimm EA, Klimpel GR (1993) Tumor necrosis factor alpha binding to bacteria: evidence for high-affinity receptor and alteration of bacterial virulence properties. Infect Immun 61:830-835.
37. Männel DM, Ruschoff J, Orosz P (1993) The role of TNF in tumor growth and metastasis. Res Immunol 144:364-369
38. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874
39. Menger MD, Vollmar B (1996) Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg 83:588-601
40. Michie HR (1996) Metabolism of sepsis and multiple organ failure. World J Surg 20:460-464
41. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79:319-323
42. Nieuwenhuijzen GA, Deitch EA, Goris RJ (1996) Infection, the gut and the development of the multiple organ dysfunction syndrome. Eur J Surg 162:259-273
43. O'Dwyer ST, Michie HR, Zioegler TR, Revhaug A, Smith RJ, Wilmore DW (1988) A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 123:1459-1464
44. Office of Planning and Extramural Programs and Hospital Care Statistics. Division of Health Care Statistics, National Center for Health Statistics. (1990) Increase in national hospital discharge survey rates of septicemia - United States, 1979-1987. MMWR Morb Mortal Wkly Rep 39:31-34
45. Pajkrt D (1997) Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effects of timins of recombinant human IL-10 admistration. J Immunol 158: 3971-3977
46. Pastores SM, Thakkar A, Gennis P, Katz DP, Kvetan V (1996) Post-traumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure. Acad Emerg Med 3:611-622
47. Pinsky MR (1996) Organ-specific therapy in critical illness: interfacing molecular mechanisms with physiological interventions. J Crit Care 11:95-107
48. Porat R, Clark BD, Wolff SM, Dinarello CA (1991) Enhancement of growth of virulent strains of Escherichia coli by Interleukin-1 Science 254:430-432.
49. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide (LPS) activation of human endothelial and epithelial cells is mediated by LPS-binding protein and soluble CD14. Proc Natl Acad Sci (USA) 90:2744-2748
50. Quartin AA, Schein RM, Kett DH, Peduzzi PN (1997) Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 277:1058-1063
51. Reinhart K, Wiegand-Lohnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willats S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment. MAK 195F, in patients with sepsis and septic shock: a multicenter. randomized, placebo-controlled, dose-ranging study Crit Care Med 24:733-742
52. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Schade UF, Di Padova F, Kusumoto S, Schumann RR (1996) Bacterial endotoxin: chemical constitution, biological recognition, host response. and immunological detoxification. Curr Top Microbiol Immunol 216:39-81
53. Rietschel ET, Brade H (1992) Bacterial endotoxins. Sci Am 267:54-61
54. Rietschel ET, Brade L, Schade U, Seydel U, Zähringer U, Kusomoto S Brade H (1988) Bacterial endotoxins: properties and structure of biologically active domains. In: Surface structures of microorganisms and their interaction with the mammalian host. Verlag Chemie, Weinheim, pp 1-41
55. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zaehringer U, Seydel U, Di Padova F, Schreier M, Brade H (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217-225.
56. Saadia R, Schein M, MacFarlane C, Boffard KD (1990) Gut barrier function and the surgeon. Br J Surg 77:487-492
57. Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, Montani C, Magni E (1995) The Italian Sepsis study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis, and septic shock Intensive Care Med 21 [Suppl 2]:S244-249
58. Schletter J, Brade H, Brade L, Krüger C, Loppnow H, Kusomoto S, Rietschel ET, Flad HD, Ulmer AJ (1995) Binding of lipopolysaccharide (LPS) to an 80 kDa membrane protein of human cells is mediated by soluble CD 14 and LPS-binding proetin. Infect Immun 63:2576-2580
59. Schromm AB, Brandenburg K, Rietschel ET, Flad H-D, Carroll SF. Seydel U (1996) Lipopolysaccharide-binding protein mediates CD14-indepdendent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Letters 399:267-271
60. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide-binding protein. Science 249:1429-1431
61. Schwab JH (1977) In: Schlessinger D (ed) Microbiology 1977. Am Soc Microbiol Washington DC, pp 366-373
62. Seydel U, Labischinsky H, Kastowsky M, Brandenburg K (1993) Phase behavior, supramolecular structure, and molecular conformation of Lipopolysaccharide. Immunobiol 187:191-211
63. Simons RK, Hoyt DB, Winchell RJ, Rose RM, Holbrook T (1996) Elevated selectin levels after severe trauma: a marker for sepsis and organ failure and a potential target for immunmodulatory therapy. J Trauma 41:653-662
64. Sparwasser T, Miethke T, Lipford G, Borschert K, Häcker H, Heeg K, Wagner H (1997) Bacterial DNA causes septic shock. Nature 386:336-337
65. Spengler RN, Spengler ML, Lincoln P, Rwemick DG, Stricter RM, Kunkel SL (1989) Dynamics of dibutyryl cyclic AMP-and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha aene expression. Infect Immun 57:2837-2842
66. Stelter F, Berheiden R, Menzel R, Jack RS, Witt S, Fan XL, Pfister M, Schütt C (1997) Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem 243:100-109
67. Stilwell M, Caplan ES (1988) The septic multiple-trauma patient. Crit Care Clin 4:345-368
68. Swank GM, Deitch EA (1996) Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20:411-417
69. Takayama K, Mitchell DH, Din ZZ, Mukerjee P, Li C, Coleman DL (1994) Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the limulus amebocyte lysate assay and in inducing egr-1 mRNA in murine peritonal macrophages. J Biol Chem 269:2241-2244
70. Ulevitch RJ, Tobias PS (1994) Recognition of endotoxin by cells leading to transmembrane signalling. Curr Opin Immunol 6: 125-130
71. 125I-LPS. Infect Immun 60:5145-5152
72. Vita N, Lefort S, Sozzani P, Reeb R, Richards S, Borysiewicz LK, Ferrara P, Labeta MO (1997) Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. J Immunol 158:3457-3462
73. Weidemann B, Schletter J, Dziarski R, Kusumoto S, Stelter F, Rietschel ET, Flad H-D, Ulmer AJ (1997) Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 65:858-864
74. Woltmann A, Kress H-G (1991) Prognostischer Wert der kutanen verzoegerten Immunreaktion nach Polytrauma im Vergleich mit anderen klinischen Parametern. Anaesthesist 40:276-281
75. Wright SD (1991) Multiple receptors for endotoxin. Curr Opin Immunol 3:83-90
76. Wright SD, Jong MTC (1986) Adhesion-promoting receptors on human macrophages recognize E. coli by binding to lipopolysaccharide. J Exp Med 164:1876-1888
77. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14. a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433
78. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180:1025-1035
79. Zähringer U, Lindner B, Rietschel ET (1994) Molecular structure of lipid A. the endotoxic center of bacterial lipopolysaccharide. Adv Carbohydr Chem Biochem 50:211-276
80. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW (1988) Increased intestinal permeability associated with infection in burn patients. Arch Surg 123:1313-1319